Stock data
West Pharmaceutical Services, Inc. (WST)
West Pharmaceutical Services, Inc. (WST) reported revenue of US$3.07B and net income of US$493.70M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$3.07B | US$1.10B | US$584.90M | US$493.70M | — |
| 2024 | US$2.89B | US$998.50M | US$569.90M | US$492.70M | — |
| 2023 | US$2.95B | US$1.13B | US$676.00M | US$593.40M | — |
| 2022 | US$2.89B | US$1.14B | US$734.00M | US$585.90M | — |
| 2021 | US$2.83B | US$1.18B | US$752.30M | US$661.80M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$872.30M | US$154.00M | — |
| 2026-03-31 | US$844.90M | US$138.80M | — |
| 2025-12-31 | US$805.00M | US$132.10M | — |
| 2025-09-30 | US$804.60M | US$140.00M | — |
| 2025-06-30 | US$766.50M | US$131.80M | — |
| 2025-03-31 | US$698.00M | US$89.80M | — |
| 2024-12-31 | US$748.80M | US$130.10M | — |
| 2024-09-30 | US$746.90M | US$136.00M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.